Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Psychiatry (34)
- Schizophrenia (19)
- Psychosis (10)
- Suicide (9)
- Depression (7)
-
- Mumbai (6)
- Assessment (4)
- Risk (4)
- Risk assessment (3)
- Antidepressant (2)
- Antipsychotic drugs (2)
- Cannabis (2)
- Catatonia (2)
- Clinical assessment (2)
- Instrument (2)
- Paliperidone (2)
- Public Health (2)
- Schizoaffective disorder (2)
- Stigma (2)
- Treatment resistance (2)
- Atypical antipsychotic (1)
- Behaviour (1)
- Brain (1)
- Case-based learning (1)
- Clinical interview (1)
- Clinical psychiatry (1)
- Clozapine (1)
- Cognition (1)
- Cognitive enhancement (1)
- Comorbidity (1)
- File Type
Articles 31 - 48 of 48
Full-Text Articles in Medicine and Health Sciences
Outcome In Schizophrenia: How Good Is "Good Outcome" Schizophrenia In Long-Term In Developing Countries, Amresh Srivastava, Meghan Thakar, Nilesh Shah, Larry Stitt
Outcome In Schizophrenia: How Good Is "Good Outcome" Schizophrenia In Long-Term In Developing Countries, Amresh Srivastava, Meghan Thakar, Nilesh Shah, Larry Stitt
Amresh Srivastava
No abstract provided.
Complexity And Limitations Of Stress-Endocrine Research In Mental Health, Amresh Srivastava
Complexity And Limitations Of Stress-Endocrine Research In Mental Health, Amresh Srivastava
Amresh Srivastava
No abstract provided.
Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 1), Amresh Srivastava
Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 1), Amresh Srivastava
Amresh Srivastava
No abstract provided.
Brain, Mind And Behaviour - Emerging Biological Connections, Amresh Srivastava
Brain, Mind And Behaviour - Emerging Biological Connections, Amresh Srivastava
Amresh Srivastava
No abstract provided.
Baseline Serum Prolactinin Drug Naïve First Episode Schizophrenia Predicts A Positive Clinical And Social Outcome At Five Years, Post Discharge Follow-Up, Amresh Srivastava, Manoj Tamhane, Meghana Thakar, Yves Bureau, Nilesh Shah
Baseline Serum Prolactinin Drug Naïve First Episode Schizophrenia Predicts A Positive Clinical And Social Outcome At Five Years, Post Discharge Follow-Up, Amresh Srivastava, Manoj Tamhane, Meghana Thakar, Yves Bureau, Nilesh Shah
Amresh Srivastava
Serum prolactinis an indicator of tuberoinfundibulardopamine activity. It is reported to increase in wide variety of mental illnesses. It has close relationship with antipsychotic therapy. However, its relationship with psychopathology and outcome is not clear. Serum prolactinlevel was measured in 30 male and 30 female drug naive patients of schizophrenia. Subsequently, these patients were treated with antipsychotics. The severity of psychopathology at the baseline and subsequent improvement at the end of 3 weeks and 6 weeks was assessed on modified brief psychiatric rating scale (mBPRS). Available to follow up at five years 18 males & 22 females patients were reassessed …
Atypical Antipsychotics And Cognitive Enhancement In Schizophrenia: The Current Status, Amresh Srivastava
Atypical Antipsychotics And Cognitive Enhancement In Schizophrenia: The Current Status, Amresh Srivastava
Amresh Srivastava
No abstract provided.
Interface Of Cannabis And Early Psychosis--Priorities In Research And Service Development, Amresh Srivastava
Interface Of Cannabis And Early Psychosis--Priorities In Research And Service Development, Amresh Srivastava
Amresh Srivastava
Introduction: cannabis continues to affect mental health. Its abuse is on rise globally. In Canada a rise by 30% in last ten years has been observed in high school students. Interrelationship of cannabis with psychosis and schizophrenia is a complex one. Cannabis is highly comorbid with psychosis, & related to functional disability and outcome. It poses several challenges in understanding causal relationship for comorbidity, underlying neurochemical basis and specifics of service development. Prevalence of Cannabis varies from 20 to 50% early psychosis. Objective of this paper is to review available literature to identify challenges for newer targets of research and …
Identifying Schizophrenia: Paradigm Shift ‘The Uhr Research’, Amresh Srivastava
Identifying Schizophrenia: Paradigm Shift ‘The Uhr Research’, Amresh Srivastava
Amresh Srivastava
No abstract provided.
Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 2), Amresh Srivastava
Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 2), Amresh Srivastava
Amresh Srivastava
No abstract provided.
Assessment In Crisis, Amresh Srivastava
Perspectives In Social Outcome Of Schizophrenia, Amresh Shrivastava
Perspectives In Social Outcome Of Schizophrenia, Amresh Shrivastava
Amresh Srivastava
No abstract provided.
Prescribing Practices Of Clozapine In India: Results Of A Opinion Survey Of Psychiatrists, Amresh Shrivastava, Nilesh Shah
Prescribing Practices Of Clozapine In India: Results Of A Opinion Survey Of Psychiatrists, Amresh Shrivastava, Nilesh Shah
Amresh Srivastava
No abstract provided.
Metro-Urbam Mental Health In Developing Countries: From Origin To Outcome: An Indian Experience, Amresh Srivastava
Metro-Urbam Mental Health In Developing Countries: From Origin To Outcome: An Indian Experience, Amresh Srivastava
Amresh Srivastava
Metro-Urban Mental health in developing countries: from origins to outcome: an Indian experience
Amresh Shrivastava: MD,DPM,MRCPsych, Executive Director: Mental Health Resource Foundation, & Prerana Charitable Trust, Mumbai, India. Assistant professor, Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
Address of presenting author E Mail: dr.amresh@gmail.com 467, Sunset Drive, Regional Mental Health care, St.Thomas, Ontario, Canada, N5H 3V9 Phone: 519-631-8510 x 49252, fax 519-631-2512. & 519-641-3833 The life of the mentally ill in large metropolitan areas is presumed to be more Challenging. The impact of urbanization on service utilization and outcome is not clearly known. The present paper discusses …
Stigma And Discrimination: The Mumbai Experience, Amresh Srivastava
Stigma And Discrimination: The Mumbai Experience, Amresh Srivastava
Amresh Srivastava
Title: Stigma & Discrimination: The Mumbai Experience
Main Author: Amresh Shrivastava MD, DPM, MRCPsych, University of Western Ontario, London, Ontario, Canada.
Co-Authors: Gopa Sarkhel, MA, Iyer Sunita MA, Thakar Meghana MA, Shah Nilesh, MD, DPM
Address of Presenter: Executive Director, Mental health foundation of India (PRERANA Charitable Trust) Mumbai, India; Currently at Department of Psychiatry, The University of Western Ontario, London, Ontario, Canada Address: Regional mental health care, 467 Sunset Drive, St. Thomas, N5N 3V9, St. Thomas, Ontario, Canada Phone: 1-5196318510; Fax: 1-519-631-2512. E-mail: amresh.edu@gmail.com
Background: People with schizophrenia suffer from stigma and discrimination to a great extent, and this …
Stigma And Discrimination : Mumbai Experience, Amresh Srivastava
Stigma And Discrimination : Mumbai Experience, Amresh Srivastava
Amresh Srivastava
Title: Stigma & Discrimination: The Mumbai Experience Main Author: Amresh Shrivastava MD, DPM, MRCPsych, University of Western Ontario, London, Ontario, Canada. Co-Authors: Gopa Sarkhel, MA, Iyer Sunita MA, Thakar Meghana MA, Shah Nilesh, MD, DPM Address of Presenter: Executive Director, Mental health foundation of India (PRERANA Charitable Trust) Mumbai, India; Currently at Department of Psychiatry, The University of Western Ontario, London, Ontario, Canada Address: Regional mental health care, 467 Sunset Drive, St. Thomas, N5N 3V9, St. Thomas, Ontario, Canada Phone: 1-5196318510; Fax: 1-519-631-2512. E-mail: amresh.edu@gmail.com Background: People with schizophrenia suffer from stigma and discrimination to a great extent, and this …
Risk Assessment For Suicide Behaviour : Clinical Challenges, Amresh Srivastava, Charles Nelson
Risk Assessment For Suicide Behaviour : Clinical Challenges, Amresh Srivastava, Charles Nelson
Amresh Srivastava
This is an audio-visual about risk assessment of suicide behavior. Part 1. Reformulating the concept of RISK and a New instrument for assessment: Risk assessment is an important clinical responsibility, which can be ‘life-saving’. Literature on risk factors has become voluminous; however a traditional risk assessment does not take into account the most relevant factors. This reflects the prevailing conceptualization of risk, which has not been fully and completely tied to clinical outcomes. Psychopathology is currently understood in biopsychosocial terms. A more progressive conceptualization of risk should consider the interplay of both, risk and protective factors. The present work proposes …
Clinical Skills In Psychiatric Assessment: An Educational Module, Amresh Srivastava
Clinical Skills In Psychiatric Assessment: An Educational Module, Amresh Srivastava
Amresh Srivastava
No abstract provided.
Risk Assessment For Suicide Behaviour, Amresh Srivastava, Charles Nelson, Megan Johnston
Risk Assessment For Suicide Behaviour, Amresh Srivastava, Charles Nelson, Megan Johnston
Amresh Srivastava
This is an audio-visual about risk assessment of suicide behavior. Part 1. Reformulating the concept of RISK and a New instrument for assessment: Risk assessment is an important clinical responsibility, which can be ‘life-saving’. Literature on risk factors has become voluminous; however a traditional risk assessment does not take into account the most relevant factors. This reflects the prevailing conceptualization of risk, which has not been fully and completely tied to clinical outcomes. Psychopathology is currently understood in biopsychosocial terms. A more progressive conceptualization of risk should consider the interplay of both, risk and protective factors. The present work proposes …